selected publications
-
academic article
-
Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients.
Psychological Medicine.
49.
2019
Sleep efficiency and neurophysiological patterns in middle‐aged men are associated with cognitive change over their adult life course.
Journal of Sleep Research.
28.
2019
Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia..
Schizophrenia Bulletin.
44.
2018
Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial.
Psychopharmacology.
235.
2018
Delay aversion and Executive Functioning in adults with Attention-Deficit/Hyperactivity Disorder: Before and after stimulant treatment.
The International Journal of Neuropsychopharmacology.
21.
2018
Examining speed of processing of facial emotion recognition in individuals at ultra-high risk for psychosis: Associations with symptoms and cognition.
Schizophrenia Research.
195.
2018
Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register.
Biological Psychiatry.
83.
2018
Overlapping and disease specific trait, response, and reflection impulsivity in adolescents with first-episode schizophrenia spectrum disorders or attention-deficit/hyperactivity disorder.
Psychological Medicine.
48.
2018
Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II).
The BMJ.
356.
2017
Is an Early Age at Illness Onset in Schizophrenia Associated With Increased Genetic Susceptibility? Analysis of Data From the Nationwide Danish Twin Register.
EBioMedicine.
18.
2017
Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
Psychological Medicine.
47.
2017
Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis.
Acta Psychiatrica Scandinavica.
135.
2017
Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo.
European Archives of Psychiatry and Clinical Neuroscience.
267.
2017
No cognitive‐enhancing effect of GLP‐1 receptor agonism in antipsychotic‐treated, obese patients with schizophrenia.
Acta Psychiatrica Scandinavica.
136.
2017
Passive Double-Sensory Evoked Coherence Correlates with Long-Term Memory Capacity.
Frontiers in Human Neuroscience.
11.
2017
Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial..
The Journal of Clinical Psychiatry.
78.
2017
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
The Lancet Psychiatry.
4.
2017
SA37. Cognition and White Matter Integrity in Antipsychotic-Naive First-Episode Schizophrenia Patients.
Schizophrenia Bulletin.
43.
2017
Testing a decades’ old assumption: Are individuals with lower sensory gating indeed more easily distracted?.
Psychiatry Research.
255.
2017
The Effect of Positive Symptoms on Social Cognition in First-Episode Schizophrenia Is Modified by the Presence of Negative Symptoms.
Neuropsychology.
31.
2017
Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.
Translational Psychiatry.
7.
2017
‘No cognitive‐enhancing effect of GLP‐1 receptor agonism in antipsychotic‐treated, obese patients with schizophrenia’: authors' response.
Acta Psychiatrica Scandinavica.
136.
2017
4.17 QUETIAPINE EXTENDED RELEASE VERSUS ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH PSYCHOSIS IN THE RANDOMIZED, BLINDED CLINICAL TOLERABILITY AND EFFICACY OF ANTIPSYCHOTICS (TEA) TRIAL.
Journal of the American Academy of Child & Adolescent Psychiatry.
55.
2016
Are Weight Status and Cognition Associated? An Examination of Cognitive Development in Children and Adolescents with Anorexia Nervosa 1 Year after First Hospitalisation.
European Eating Disorders Review.
24.
2016
Cognitive Change during the Life Course and Leukocyte Telomere Length in Late Middle-Aged Men.
Frontiers in Aging Neuroscience.
8.
2016
Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
The International Journal of Neuropsychopharmacology.
19.
2016
Melatonin and cortisol profiles in late midlife and their association with age-related changes in cognition.
Nature and Science of Sleep.
Volume 8.
2016
Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study.
Schizophrenia Research.
175.
2016
Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?.
Schizophrenia Research Cognition.
5.
2016
Subjective sleep quality and daytime sleepiness in late midlife and their association with age-related changes in cognition.
Sleep Medicine.
17.
2016
Association Study of CHRNA7 Promoter Variants with Sensory and Sensorimotor Gating in Schizophrenia Patients and Healthy Controls: A Danish Case–Control Study.
NeuroMolecular Medicine.
17.
2015
Cognitive Profile of Children and Adolescents with Anorexia Nervosa.
European Eating Disorders Review.
23.
2015
Increased deoxythymidine triphosphate levels is a feature of relative cognitive decline.
Mitochondrion.
25.
2015
Influence of early life characteristics on psychiatric admissions and impact of psychiatric disease on inflammatory biomarkers and survival: a Danish cohort study.
World Psychiatry.
14.
2015
The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial.
Trials.
16.
2015
Association of the CHRNA7 promoter variant −86T with Tourette syndrome and comorbid obsessive-compulsive disorder.
Psychiatry Research.
219.
2014
Cognitive function in idiopathic intracranial hypertension: a prospective case–control study.
BMJ Open.
4.
2014
Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.
BMC Psychiatry.
14.
2014
Social cognition and neurocognitive deficits in first-episode schizophrenia.
Schizophrenia Research.
153.
2014
Subclinical cognitive decline in middle‐age is associated with reduced task‐induced deactivation of the brain's default mode network.
Human Brain Mapping.
35.
2014
The Relationship Between Cognitive Ability and Demographic Factors in Late Midlife.
Journal of Aging and Health.
26.
2014
Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol.
BMJ Open.
4.
2014
-
hide from search
-
Profile of cognitive deficits and associations with depressive symptoms and intelligence in chronic early‐onset schizophrenia patients.
Scandinavian Journal of Psychology.
2013
Relationship of frontal D2/3 binding potentials to cognition: a study of antipsychotic-naive schizophrenia patients.
The International Journal of Neuropsychopharmacology.
2013